지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
이용수
초록· 키워드
오류제보하기
Evidence-based medicine (EBM) has contributed to recent advancements in healthcare; the concept of EBM includes Patient and Public Involvement (PPI), along with the best research evidence and clinical expertise. That is, to provide the best healthcare services, it is necessary to consider patients’ experiences and emotion as a consumer of healthcare services, together with clinicians’ competency. Therefore, PPI is required for EBM. This paper aims to examine the international trends and the implication of public involvement in healthcare technology assessment (HTA) that is considered the system based on EBM. In the process of various research and analysis related to technology assessment in healthcare, patients and public can provide part of evidence as participants in interviews, questionnaires, other forms of consultation and qualitative research. In detail, it is possible to provide a perspective on social implications for specific health conditions, diseases, and treatments, along with knowledge by experiences and burden of disease, diagnosis and treatment, treatment route, cost-effectiveness analysis, etc. In the UK’s National Institute for Health Research, it is recommended that patients and public engage in the entire cycle of conducting the research, and deriving and utilizing the research results, starting from a planning stage such as identifying research topics. PPI in the specialized area such as healthcare can provide unique and valuable insights, as they are users of healthcare services and payers of healthcare costs. Additionally, they contribute to cost saving by providing effective and reliable advices when designing, implementing, and evaluating the research. With an open awareness of embracing various perspectives on decision-making in the process of HTA, PPI has great implications on establishing roles and functions of HTA for developing the national healthcare system by ensuring appropriate medical coverage and medical services.
목차
등록된 정보가 없습니다.
참고문헌 (15)
참고문헌 신청
이영희 / 2011 / 과학기술과 민주주의: 시민을 위한, 시민에 의한 과학기술 / Moonji Publishing Co.,Ltd :216~217
Park S / 2014 / Analysis of policy on the adoption and diffusion of new healthcare technology / Korea Institute for Health and Social Affairs :177~179
Harrison S / 2002 / Guest editorial : public and user ‘involvement’ in the UK National Health Service / Health Soc Care Community 10:63~66
hra.nhs.uk
invo.org.uk
Park S / 2014 / Analysis of policy on the adoption and diffusion of new healthcare technology / Korea Institute for Health and Social Affairs :177~179
Harrison S / 2002 / Guest editorial : public and user ‘involvement’ in the UK National Health Service / Health Soc Care Community 10:63~66
hra.nhs.uk
invo.org.uk
함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
How to understand and conduct evidence-based medicine
Korean Journal of Anesthesiology
2016 .01
-
HTAi의 INTEGRATE-Health Technology Assessment 프로젝트와 국내 시사점
보건의료기술평가
2019 .01
-
환자안전과 보건의료기술평가
보건의료기술평가
2016 .06
-
Advantages and Disadvantages of Long-term Proton Pump Inhibitor Use
Journal of Neurogastroenterology and Motility (JNM)
2018 .01
-
Association of proton pump inhibitor use with renal outcomes in patients with coronary artery disease
Kidney Research and Clinical Practice
2018 .01
-
A Systematic Review and Meta-analysis of Randomized Control Trials: Combination Treatment With Proton Pump Inhibitor Plus Prokinetic for Gastroesophageal Reflux Disease
Journal of Neurogastroenterology and Motility (JNM)
2021 .01
-
Extension block and direct pinning methods for mallet fracture: A comparative study
Archives of plastic surgery : APS
2018 .01
-
디지털헬스 정책환경의 국제 동향과 의료기술평가에 대한 시사점
보건의료기술평가
2018 .01
-
시장진입을 위한 치료재료 신의료기술평가 제도: 의료법, 의료기기법, 국민건강보험법 중심으로
보건의료기술평가
2016 .12
-
Changes in serum magnesium concentration after use of a proton pump inhibitor in patients undergoing percutaneous coronary intervention
Kidney Research and Clinical Practice
2015 .01
-
치의학분야 사례분석을 통한 신의료기술평가 현황 평가
대한치과의사협회지
2019 .05
-
Additive Effects of Rebamipide Plus Proton Pump Inhibitors on the Expression of Tight Junction Proteins in a Rat Model of Gastro-Esophageal Reflux Disease
Gut and Liver
2018 .01
-
Clinicopathologic Analysis of Proton Pump Inhibitor-Responsive Esophageal Eosinophilia in Korean Patients
Gut and Liver
2016 .01
-
Is It Useful to Administer Probiotics Together With Proton Pump Inhibitors in Children With Gastroesophageal Reflux?
Journal of Neurogastroenterology and Motility (JNM)
2018 .01
-
Multiple Criteria Decision Analysis (MCDA) in Health Technology Assessment: Review of Literature on MCDA Methodology and Decision Criteria
보건의료기술평가
2017 .12
-
Histamine-2 Receptor Antagonists and Proton Pump Inhibitors Are Associated With Reduced Risk of SARS-CoV-2 Infection Without Comorbidities Including Diabetes, Hypertension, and Dyslipidemia: A Propensity Score-Matched Nationwide Cohort Study
Journal of Korean Medical Science
2023 .04
-
Proton-pump Inhibitor Use and Fracture Risk: An Updated Systematic Review and Meta-analysis
대한골대사학회지
2018 .01
-
한의학에서 근거중심진료와 표준화의 필요성 - 2008, 2011, 2014년 한방의료이용실태조사(보건복지부)중 소비자의견을 중심으로
대한예방한의학회지
2016 .12
-
접촉성 육아종 치료에 비강 스테로이드 분무가 미치는 영향
대한후두음성언어의학회지
2018 .01
-
Evidence-based Medicine versus the Conventional Approach to Journal Club Sessions: Which One Is More Successful in Teaching Critical Appraisal Skills?
전남의대학술지
2016 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0